A Phase 1 Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection
Clinical trial NCT04248426 · COMPLETED
Trial details
- NCT number
- NCT04248426
- Sponsor
- Antios Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-05
- Primary completion
- 2021-05-18
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.